Inactive Instrument

Pharma-Bio Serv, Inc. Stock price Other OTC

Equities

PBSV

US71711N1000

Business Support Services

Sales 2024 * 12.8M Sales 2025 * 20.2M Capitalization 19.45M
Net income 2024 * - Net income 2025 * - EV / Sales 2024 * 1.52 x
Net cash position 2024 * - Net cash position 2025 * - EV / Sales 2025 * 0.96 x
P/E ratio 2024 *
-
P/E ratio 2025 *
-
Employees -
Yield 2024 *
-
Yield 2025 *
-
Free-Float 34.4%
More Fundamentals * Assessed data
Dynamic Chart
Pharma-Bio Serv, Inc. Reports Earnings Results for the First Quarter Ended January 31, 2024 CI
Pharma-Bio Serv, Inc. Reports Earnings Results for the Full Year Ended October 31, 2023 CI
Tranche Update on Pharma-Bio Serv, Inc.'s Equity Buyback Plan announced on June 16, 2014. CI
Pharma-Bio Serv, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended July 31, 2023 CI
Tranche Update on Pharma-Bio Serv, Inc.'s Equity Buyback Plan announced on June 16, 2014. CI
Pharma-Bio Serv, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended April 30, 2023 CI
Tranche Update on Pharma-Bio Serv, Inc.'s Equity Buyback Plan announced on June 16, 2014. CI
Tranche Update on Pharma-Bio Serv, Inc.'s Equity Buyback Plan announced on June 16, 2014. CI
Pharma-Bio Serv, Inc. Reports Earnings Results for the Full Year Ended October 31, 2022 CI
Tranche Update on Pharma-Bio Serv, Inc.'s Equity Buyback Plan announced on June 16, 2014. CI
Pharma-Bio Serv, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended July 31, 2022 CI
Tranche Update on Pharma-Bio Serv, Inc.'s Equity Buyback Plan announced on June 16, 2014. CI
Pharma-Bio Serv, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended April 30, 2022 CI
Tranche Update on Pharma-Bio Serv, Inc.'s Equity Buyback Plan announced on June 16, 2014. CI
Pharma-Bio Serv, Inc. Reports Earnings Results for the First Quarter Ended January 31, 2022 CI
More news
Managers TitleAgeSince
Chief Executive Officer 53 10-12-31
Director of Finance/CFO 64 07-11-04
Chief Operating Officer - 10-12-31
Members of the board TitleAgeSince
Director/Board Member 61 03-12-31
Chairman 68 06-01-24
Director/Board Member 78 06-01-24
More insiders
Pharma-Bio Serv, Inc. is a compliance and technology transfer services consulting company. The Company operates through four segments: Puerto Rico technical compliance consulting, United States technical compliance consulting, Europe technical compliance consulting, and Puerto Rico microbiological and chemical laboratory testing division (Lab). The Company provides a range of compliance-related consulting services. The Company provides microbiological testing services and chemical testing services through its laboratory testing facility in Puerto Rico. The Company's technical consulting services include regulatory compliance, validation, technology transfer, engineering, project management and process support. The Company markets its services to pharmaceutical, chemical, biotechnology, medical devices, cosmetic and food industries, and allied products companies in Puerto Rico, the United States, Europe and Brazil.
More about the company
  1. Stock
  2. Equities
  3. Stock Pharma-Bio Serv, Inc.
  4. Stock Pharma-Bio Serv, Inc. - Other OTC